Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?

dc.contributor.authorMall, Anwar S
dc.contributor.authorHabte, Habtom
dc.contributor.authorMthembu, Yolanda
dc.contributor.authorPeacocke, Julia
dc.contributor.authorde Beer, Corena
dc.date.accessioned2017-10-17T10:33:54Z
dc.date.available2017-10-17T10:33:54Z
dc.date.issued2017-10-06
dc.date.updated2017-10-08T03:27:58Z
dc.description.abstractBackground: Mucins are large O-linked glycosylated proteins which give mucus their gel-forming properties. There are indications that mucus and mucins in saliva, breast milk and in the cervical plug inhibit the human immunodeficiency virus (HIV-1) in an in vitro assay. Main body of abstract: Crude mucus gels form continuous layers on the epithelial surfaces of the major internal tracts of the body and protect these epithelial surfaces against aggressive luminal factors such as hydrochloric acid and pepsin proteolysis in the stomach lumen, the movement of hard faecal pellets in the colon at high pressure, the effects of shear against the vaginal epithelium during intercourse and the presence of foreign substances in the respiratory airways. Tumour-associated epitopes on mucins make them suitable as immune-targets on malignant epithelial cells, rendering mucins important as diagnostic and prognostic markers for various diseases, even influencing the design of mucin-based vaccines. Sub-Saharan Africa has the highest prevalence of HIV-AIDS in the world. The main points of viral transmission are via the vaginal epithelium during sexual intercourse and mother-to-child transmission during breast-feeding. There have been many studies showing that several body fluids have components that prevent the transmission of HIV-1 from infected to non-infected persons through various forms of contact. Crude saliva and its purified mucins, MUC5B and MUC7, and the purified mucins from breast milk, MUC1 and MUC4 and pregnancy plug cervical mucus (MUC2, MUC5AC, MUC5B and MUC6), inhibit HIV-1 in an in vitro assay. There are conflicting reports of whether crude breast-milk inhibits HIV-1 in an in vitro assay. However studies with a humanised BLT mouse show that breast-milk does inhibit HIV and that breast-feeding is still advisable even amongst HIV-positive women in under-resourced areas, preferably in conjunction with anti-retroviral treatment. Conclusion: These findings raise questions of how such a naturally occurring biological substance such as mucus, with remarkable protective properties of epithelial surfaces against aggressive luminal factors in delicate locations, could be used as a tool in the fight against HIV-AIDS, which has reached epidemic proportions in sub-Saharan Africa.
dc.identifier.apacitationMall, A. S., Habte, H., Mthembu, Y., Peacocke, J., & de Beer, C. (2017). Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?. <i>Virology Journal</i>, http://hdl.handle.net/11427/25703en_ZA
dc.identifier.chicagocitationMall, Anwar S, Habtom Habte, Yolanda Mthembu, Julia Peacocke, and Corena de Beer "Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?." <i>Virology Journal</i> (2017) http://hdl.handle.net/11427/25703en_ZA
dc.identifier.citationVirology Journal. 2017 Oct 06;14(1):192
dc.identifier.ris TY - Journal Article AU - Mall, Anwar S AU - Habte, Habtom AU - Mthembu, Yolanda AU - Peacocke, Julia AU - de Beer, Corena AB - Background: Mucins are large O-linked glycosylated proteins which give mucus their gel-forming properties. There are indications that mucus and mucins in saliva, breast milk and in the cervical plug inhibit the human immunodeficiency virus (HIV-1) in an in vitro assay. Main body of abstract: Crude mucus gels form continuous layers on the epithelial surfaces of the major internal tracts of the body and protect these epithelial surfaces against aggressive luminal factors such as hydrochloric acid and pepsin proteolysis in the stomach lumen, the movement of hard faecal pellets in the colon at high pressure, the effects of shear against the vaginal epithelium during intercourse and the presence of foreign substances in the respiratory airways. Tumour-associated epitopes on mucins make them suitable as immune-targets on malignant epithelial cells, rendering mucins important as diagnostic and prognostic markers for various diseases, even influencing the design of mucin-based vaccines. Sub-Saharan Africa has the highest prevalence of HIV-AIDS in the world. The main points of viral transmission are via the vaginal epithelium during sexual intercourse and mother-to-child transmission during breast-feeding. There have been many studies showing that several body fluids have components that prevent the transmission of HIV-1 from infected to non-infected persons through various forms of contact. Crude saliva and its purified mucins, MUC5B and MUC7, and the purified mucins from breast milk, MUC1 and MUC4 and pregnancy plug cervical mucus (MUC2, MUC5AC, MUC5B and MUC6), inhibit HIV-1 in an in vitro assay. There are conflicting reports of whether crude breast-milk inhibits HIV-1 in an in vitro assay. However studies with a humanised BLT mouse show that breast-milk does inhibit HIV and that breast-feeding is still advisable even amongst HIV-positive women in under-resourced areas, preferably in conjunction with anti-retroviral treatment. Conclusion: These findings raise questions of how such a naturally occurring biological substance such as mucus, with remarkable protective properties of epithelial surfaces against aggressive luminal factors in delicate locations, could be used as a tool in the fight against HIV-AIDS, which has reached epidemic proportions in sub-Saharan Africa. DA - 2017-10-06 DB - OpenUCT DO - 10.1186/s12985-017-0855-9 DP - University of Cape Town J1 - Virology Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2017 T1 - Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus? TI - Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus? UR - http://hdl.handle.net/11427/25703 ER - en_ZA
dc.identifier.urihttp://dx.doi.org/10.1186/s12985-017-0855-9
dc.identifier.urihttp://hdl.handle.net/11427/25703
dc.identifier.vancouvercitationMall AS, Habte H, Mthembu Y, Peacocke J, de Beer C. Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?. Virology Journal. 2017; http://hdl.handle.net/11427/25703.en_ZA
dc.language.isoen
dc.publisherBioMed Central
dc.publisher.departmentDepartment of Surgeryen_ZA
dc.publisher.facultyFaculty of Health Sciencesen_ZA
dc.publisher.institutionUniversity of Cape Town
dc.rights.holderThe Author(s).
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceVirology Journal
dc.source.urihttps://virologyj.biomedcentral.com/
dc.subject.otherMucus
dc.subject.otherMucins
dc.subject.otherHIV-AIDS
dc.subject.otherSaliva
dc.subject.otherBreast milk
dc.subject.otherCervical
dc.titleMucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?
dc.typeJournal Article
uct.type.filetypeText
uct.type.filetypeImage
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Mall_2017_Article.pdf
Size:
568.29 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.72 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections